SBRA (STOCKS)
Sabra Healthcare REIT, Inc.
$18.356800
-0.373200 (-1.99%)
Prev close: $18.730000
Company Information
- Exchange
- XNAS
- Sector
- Finance
- Industry
- Real Estate Investment Trusts
- CEO
- Richard K. Matros
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,685.69M
- Employees
- 50
- P/E (TTM)
- 29.64
- P/B (TTM)
- 1.70
- Dividend Yield
- 640.68%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
6
Buy
9
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.16 | $0.17 | -0.0090 | -5.33% |
|
Dec 2025 (Q4)
|
$0.11 | $0.18 | -0.0663 | -37.61% |
|
Sep 2025 (Q3)
|
$0.09 | $0.19 | -0.0965 | -51.74% |
|
Jun 2025 (Q2)
|
$0.27 | $0.18 | +0.0915 | +51.26% |
Financial Statements
| Revenues | $812.84M |
| Benefits Costs and Expenses | $660.50M |
| Costs And Expenses | $660.50M |
| Operating Expenses | $660.50M |
| Operating Income/Loss | $152.35M |
| Income/Loss Before Equity Method Investments | $152.35M |
| Income/Loss From Continuing Operations After Tax | $150.40M |
| Income/Loss From Continuing Operations Before Tax | $152.35M |
| Income/Loss From Equity Method Investments | $5.62M |
| Income Tax Expense/Benefit | $1.95M |
| Net Income/Loss | $156.02M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$166.00K |
| Net Income/Loss Attributable To Parent | $156.19M |
| Net Income/Loss Available To Common Stockholders, Basic | $156.19M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.63 |
| Diluted Earnings Per Share | $0.63 |
| Basic Average Shares | 732,724,638 |
| Diluted Average Shares | 743,356,852 |
| Assets | $5.59B |
| Current Assets | $5.59B |
| Noncurrent Assets | $0.00 |
| Liabilities | $2.80B |
| Current Liabilities | $2.80B |
| Noncurrent Liabilities | $0.00 |
| Long-term Debt | $2.67B |
| Equity | $2.79B |
| Equity Attributable To Noncontrolling Interest | $1.88M |
| Equity Attributable To Parent | $2.79B |
| Liabilities And Equity | $5.59B |
| Net Cash Flow From Operating Activities | $366.71M |
| Net Cash Flow From Operating Activities, Continuing | $366.71M |
| Net Cash Flow From Investing Activities | -$466.61M |
| Net Cash Flow From Investing Activities, Continuing | -$466.61M |
| Net Cash Flow From Financing Activities | $194.10M |
| Net Cash Flow From Financing Activities, Continuing | $194.10M |
| Exchange Gains/Losses | $350.00K |
| Net Cash Flow | $94.55M |
| Net Cash Flow, Continuing | $94.20M |
| Comprehensive Income/Loss | $141.50M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$166.00K |
| Comprehensive Income/Loss Attributable To Parent | $141.66M |
| Other Comprehensive Income/Loss | $51.02M |